Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks

dc.contributor.authorPasseron, Thierry
dc.contributor.authorHarris, John E.
dc.contributor.authorPandya, Amit G.
dc.contributor.authorSeneschal, Julien
dc.contributor.authorGrimes, Pearl
dc.contributor.authorKornacki, Deanna
dc.contributor.authorWang, Mingyue
dc.contributor.authorEzzedine, Khaled
dc.contributor.authorRosmarin, David
dc.contributor.departmentDermatology, School of Medicine
dc.date.accessioned2025-03-24T08:50:37Z
dc.date.available2025-03-24T08:50:37Z
dc.date.issued2025
dc.eprint.versionFinal published version
dc.identifier.citationPasseron T, Harris JE, Pandya AG, et al. Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks. J Eur Acad Dermatol Venereol. 2025;39(3):e251-e254. doi:10.1111/jdv.20236
dc.identifier.urihttps://hdl.handle.net/1805/46482
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1111/jdv.20236
dc.relation.journalJournal of the European Academy of Dermatology and Venereology
dc.rightsAttribution-NonCommercial 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourcePMC
dc.subjectVitiligo
dc.subjectSkin depigmentation
dc.subjectRepigmentation
dc.subjectRuxolitinib cream
dc.titleRepigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Passeron2024Repigmentation-CCBYNC.pdf
Size:
736.43 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: